<code id='AB6ACD9160'></code><style id='AB6ACD9160'></style>
    • <acronym id='AB6ACD9160'></acronym>
      <center id='AB6ACD9160'><center id='AB6ACD9160'><tfoot id='AB6ACD9160'></tfoot></center><abbr id='AB6ACD9160'><dir id='AB6ACD9160'><tfoot id='AB6ACD9160'></tfoot><noframes id='AB6ACD9160'>

    • <optgroup id='AB6ACD9160'><strike id='AB6ACD9160'><sup id='AB6ACD9160'></sup></strike><code id='AB6ACD9160'></code></optgroup>
        1. <b id='AB6ACD9160'><label id='AB6ACD9160'><select id='AB6ACD9160'><dt id='AB6ACD9160'><span id='AB6ACD9160'></span></dt></select></label></b><u id='AB6ACD9160'></u>
          <i id='AB6ACD9160'><strike id='AB6ACD9160'><tt id='AB6ACD9160'><pre id='AB6ACD9160'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:131
          Colorful broken DNA helix genome. -- health coverage from STAT
          Adobe

          In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

          The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

          advertisement

          Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Longer MASH drug regimen improved liver, Akero study finds
          Longer MASH drug regimen improved liver, Akero study finds

          AdobeAkeroTherapeuticssaidMondaythatextendingtreatmentwithitsexperimentaldrugfortheliverdiseaseknown

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

          2:04UkrainianmilitaryservicemanIgorOvcharruckholdsadefusedclusterbombfromanMSLRmissile,amongadisplay